PL2049199T3 - Kompozycje do leczenia przewlekłych zwyrodnieniowych chorób zapalnych - Google Patents

Kompozycje do leczenia przewlekłych zwyrodnieniowych chorób zapalnych

Info

Publication number
PL2049199T3
PL2049199T3 PL07786380T PL07786380T PL2049199T3 PL 2049199 T3 PL2049199 T3 PL 2049199T3 PL 07786380 T PL07786380 T PL 07786380T PL 07786380 T PL07786380 T PL 07786380T PL 2049199 T3 PL2049199 T3 PL 2049199T3
Authority
PL
Poland
Prior art keywords
compositions
treatment
inflammatory diseases
chronic degenerative
degenerative inflammatory
Prior art date
Application number
PL07786380T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37847092&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2049199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL2049199T3 publication Critical patent/PL2049199T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07786380T 2006-08-08 2007-07-27 Kompozycje do leczenia przewlekłych zwyrodnieniowych chorób zapalnych PL2049199T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06016518A EP1886712A1 (en) 2006-08-08 2006-08-08 Compositions for the treatment of chronic degenerative inflammatory conditions
EP07786380.1A EP2049199B1 (en) 2006-08-08 2007-07-27 Compositions for the treatment of chronic degenerative inflammatory conditions
PCT/EP2007/006666 WO2008017390A1 (en) 2006-08-08 2007-07-27 Compositions for the treatment of chronic degenerative inflammatory conditions

Publications (1)

Publication Number Publication Date
PL2049199T3 true PL2049199T3 (pl) 2018-11-30

Family

ID=37847092

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07786380T PL2049199T3 (pl) 2006-08-08 2007-07-27 Kompozycje do leczenia przewlekłych zwyrodnieniowych chorób zapalnych

Country Status (17)

Country Link
US (1) US7993683B2 (pl)
EP (2) EP1886712A1 (pl)
JP (1) JP5441695B2 (pl)
KR (1) KR20090040319A (pl)
CN (1) CN101500654B (pl)
AU (1) AU2007283122B2 (pl)
CA (1) CA2660695C (pl)
DK (1) DK2049199T3 (pl)
ES (1) ES2681683T3 (pl)
HU (1) HUE039554T2 (pl)
IL (1) IL196901A (pl)
NO (1) NO343552B1 (pl)
PL (1) PL2049199T3 (pl)
PT (1) PT2049199T (pl)
RU (1) RU2445114C2 (pl)
SI (1) SI2049199T1 (pl)
WO (1) WO2008017390A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014031087A1 (en) * 2012-08-21 2014-02-27 Agricultural Research Develpoment Agency (Public Organization) Natural synergistic formulations containing andrographis paniculata extracts for supporting the inhibition of cartilate degradation in degenerative joint disease
CN102809625B (zh) * 2012-08-23 2015-02-04 神威药业集团有限公司 一种穿心莲内酯有关物质的测定方法
JP6270362B2 (ja) * 2013-07-17 2018-01-31 日本水産株式会社 関節痛改善剤
JP5887318B2 (ja) 2013-09-13 2016-03-16 日本金銭機械株式会社 紙葉類収納用スタッカ
JP6386761B2 (ja) * 2014-03-19 2018-09-05 花王株式会社 インボルクリン発現抑制剤
RU2582225C1 (ru) * 2014-12-22 2016-04-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ получения противоспалительного средства
WO2017123672A1 (en) * 2016-01-12 2017-07-20 Lawrence Chan Combination treatment for inflammatory diseases
CN105640938A (zh) * 2016-01-21 2016-06-08 广西医科大学 穿心莲内酯在治疗骨关节退行性病变药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3970M (pl) * 1963-11-26 1966-02-28
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
JP4153057B2 (ja) * 1997-03-10 2008-09-17 中国化薬株式会社 Ｄ−グルクロノラクトンの製造方法
ITMI20031311A1 (it) * 2003-06-27 2004-12-28 Indena Spa Formulazioni per il trattamento di disturbi artrosici.
AU2004315105A1 (en) * 2004-02-03 2005-08-18 Universidad Austral De Chile Composition of labdane diterpenes extracted from Andrographis paniculata, useful for the treatment of autoimmune diseases, and Alzheimer disease by activation of PPR-gamma receptors

Also Published As

Publication number Publication date
EP1886712A1 (en) 2008-02-13
JP5441695B2 (ja) 2014-03-12
IL196901A0 (en) 2011-08-01
HUE039554T2 (hu) 2019-01-28
EP2049199B1 (en) 2018-06-13
CA2660695C (en) 2018-01-02
CA2660695A1 (en) 2008-02-14
NO20090562L (no) 2009-02-05
US20100047339A1 (en) 2010-02-25
NO343552B1 (no) 2019-04-01
PT2049199T (pt) 2018-08-01
AU2007283122A1 (en) 2008-02-14
HK1136230A1 (en) 2010-06-25
DK2049199T3 (en) 2018-07-23
US7993683B2 (en) 2011-08-09
ES2681683T3 (es) 2018-09-14
SI2049199T1 (sl) 2018-09-28
IL196901A (en) 2015-08-31
CN101500654B (zh) 2013-08-21
RU2445114C2 (ru) 2012-03-20
CN101500654A (zh) 2009-08-05
KR20090040319A (ko) 2009-04-23
EP2049199A1 (en) 2009-04-22
RU2009103908A (ru) 2010-08-10
WO2008017390A1 (en) 2008-02-14
AU2007283122B2 (en) 2012-08-30
JP2010500301A (ja) 2010-01-07

Similar Documents

Publication Publication Date Title
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
LT2478907T (lt) Kompozicijos vėžiui gydyti
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
CY2016017I2 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
IL192692A0 (en) Compounds for the treatment of inflammatory disorders
EP1996612A4 (en) COMPOSITIONS FOR THE TREATMENT OF CANCER
BRPI0715712A2 (pt) Composição farmacêutica
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
BRPI1014759A2 (pt) composto útil para o tratamento de doenças degenerativas e inflamatórias
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
NO20090054L (no) Antitumoral dihydropyran-2-on sammensetninger
PL2049199T3 (pl) Kompozycje do leczenia przewlekłych zwyrodnieniowych chorób zapalnych
BRPI0820198A2 (pt) composições farmacêuticas
EP2214697A4 (en) NELL-1 COMPOSITIONS
DK2224934T3 (da) Anvendelse af osteoblaster til behandling af inflammatoriske rheumatiske sygdomme
IL202502A (en) Cxcl11 for the treatment of inflammatory diseases
IL194261A0 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
FI20060790A0 (fi) Parannetut koostumukset superkondensattoreita vartenº